全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Mirabegron – a selective ß3-adrenoreceptor agonist for the treatment of overactive bladder

Full-Text   Cite this paper   Add to My Lib

Abstract:

Alka A Bhide, G Alessandro Digesu, Ruwan Fernando, Vik KhullarDepartment of Urogynaecology, St Mary's Hospital, London, United KingdomAbstract: Overactive bladder is a common condition that significantly impacts overall quality of life. Antimuscarinics are the current main pharmacological option for treatment; however, many patients fail to adhere to therapy due to troublesome side effects. Mirabegron is a new beta-3 adrenoreceptor agonist which causes detrusor smooth muscle relaxation and has been proposed to be effective for treating overactive bladder symptoms. Mirabegron has been shown to be superior to placebo for reducing the mean number of incontinence episodes per 24 hours and the mean number of micturitions per 24 hours. Side effects such as dry mouth were observed at similar or lower rates than those seen for placebo and antimuscarinics. Higher doses of mirabegron were associated with minor increases in pulse rate and mean blood pressure. Mirabegron offers a new alternative for treating overactive bladder in patients for which antimuscarinics are either not tolerated or not appropriate.Keywords: beta-3 adrenoreceptor agonist, mirabegron, overactive bladder

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133